← Back to headlines
High-Stakes Bets on Experimental Cancer Therapies Begin to Pay Off
Former Moderna executive Tal Zaks and a fellow scientist describe how their early, principle-driven investments in unconventional cancer treatments are finally yielding significant breakthroughs ahead of 2026.
5 Sept, 09:00 — 5 Sept, 09:00



